New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

Virtus LifeSci Biotech Products ETF

This ETF provides exposure to Equally Weighted US Equities

BBP performance and flow charts

Last update 9/10/2026 at 1:30 PM
Live
Closed
Last price
$103.47
-$2.05 (-1.94%) Yesterday

Performance

0.02.04.06.08.0%Aug 10Aug 17Aug 24Aug 31Sep 7

Flows

0 M2 M4 M6 M8 M10 M
1 day price range
$103.13
$104.68
52 week price range
$68.26
$109.99
1W perf
-3.97%
YTD perf
+32.02%
YTD flows
+$50M
AuM
$116M
E/R
0.34%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of September 9, 2026
1M3MYTD1Y3Y5Y
Perf.+4.09%+23.23%+32.02%+49.71%+98.63%+100.65%
Flows+$5M+$20M+$50M+$62M+$68M+$61M
Data as of September 9, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The Virtus LifeSci Biotech Products ETF is built to track the LifeSci Biotechnology Products Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderVIRTUS Investment Partners
N° of holdings66
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateDecember 16, 2014
ESGNo
TrackinsightTrackinsight

More data and info about BBP on Trackinsight

Exposure

Data as of July 31, 2026

Diversification

26.78%

Total weight of top 15 holdings out of 66

Top 15 Holdings

Crinetics Pharmaceuticals, Inc.
3.24%
Verastem, Inc.
1.98%
Nuvation Bio, Inc.
1.8%
Omeros Corp.
1.73%
Geron Corp.
1.72%
BridgeBio Pharma, Inc.
1.68%
Agios Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
BeOne Medicines Ltd.
1.64%
Kiniksa Pharmaceuticals International Plc
1.63%
Precigen, Inc.
1.62%
Xeris Biopharma Holdings, Inc.
1.61%
ACADIA Pharmaceuticals, Inc.
1.6%
Iovance Biotherapeutics, Inc.
1.6%
Rhythm Pharmaceuticals, Inc.
1.6%

Sectors

Healthcare
98.2%
Other
1.8%

Countries

USA
86.5%
Other
13.5%
Advertisement

Trading data

Last sale
9/10/2026 at 1:30 PM
$103.47
Previous close
$105.52
Consolidated volume
09/09/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+25.85%+25.14%+24.72%+26.61%
Max drawdown
-9.34%-9.59%-25.54%-37.61%
Max drawdown duration
39d48d292d586d
Time to recover
18d15d144d400d

Replication quality

Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about BBP

What type of ETF is BBP?

BBP is a Passive ETF that provides exposure to Equity assets. It is managed by VIRTUS Investment Partners.

What index does BBP track?

BBP tracks the LifeSci Biotechnology Products Total Return Index - USD, aiming to replicate its performance through full replication.

What does BBP invest in?

This ETF provides exposure to Equally Weighted US Equities. It is part of the segment: Tomorrow's Treatments.

What is the expense ratio of BBP?

The total expense ratio (TER) of BBP is 0.34%, representing the annual fee charged by the fund manager.

When was BBP launched?

BBP was launched on December 16, 2014, marking its entry into the ETF market.

Who is the issuer of BBP?

BBP is issued by VIRTUS Investment Partners.

What is the AUM of BBP?

As of September 9, 2026, BBP manages $115.83 M, reflecting the total assets held in the fund.

How has BBP performed recently?

As of September 9, 2026, BBP delivered a return of 4.09% over the past month (1M performance), 23.23% over the past three months (3M), and 32.02% year-to-date (YTD).

What are the recent fund flows for BBP?

As of September 9, 2026, BBP has seen net flows of +$5M in the past month (1M flow) and +$50M year-to-date (YTD).

How many holdings are in BBP

As of July 31, 2026, BBP holds 66 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is BBP?

As of July 31, 2026, BBP holds 66 securities, with 26.78% of its assets concentrated in its top 15 holdings.

What are the top holdings of BBP?

As of July 31, 2026, BBP holds a portfolio of 66 underlyings, with its largest positions including Crinetics Pharmaceuticals, Inc., Verastem, Inc. and Nuvation Bio, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does BBP invest in?

As of July 31, 2026, BBP has its largest geographic exposures in USA.

What sectors or themes does BBP focus on?

As of July 31, 2026, BBP is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 8, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 9, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 31, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

What’sTheFund

What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.

NYSE logo
By NYSE · August 18, 2026

Browse all educational columns

ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder